GTF2E2 and cancer: In our analysis of tumor stage relevance, we observed that GTF2E2 expression significantly increased at early stages in 12 cancer types, including BLCA, CHOL, COAD, ESCA, HNSC, KIRC, KIRP, LUAD, LUSC, OSCC, STAD, and THCA (Fig 9).